Mohini Health long-term borrowings reach Rs 115 crore
Key highlights
- Mohini Health’s consolidated long-term borrowings were Rs 115.12 crore at September 30, 2026, versus Rs 2.64 crore at March 31, 2026.
- Short-term loans and advances reached Rs 99.05 crore at September 30, 2026, from Rs 56.81 lakh at March 31, 2026.
- Mohini Health recorded Rs 112.48 crore of long-term loan proceeds and a Rs 98.48 crore cash outflow into short-term loans and advances.
- Mohini Health reported consolidated profit of Rs 5.20 crore for the half year, compared with a Rs 3.95 crore loss a year earlier.
powered by IRIS

Mohini Health & Hygiene Limited reported consolidated long-term borrowings of Rs 115.12 crore at September 30, 2026, after recording Rs 112.48 crore of long-term loan proceeds during the half year. Mohini Health’s short-term loans and advances rose to Rs 99.05 crore from Rs 56.81 lakh at March 31, 2026.
Know Mohini Health & Hygiene inside out
Results, valuation, peers and who's buying, in one view.
Why did Mohini Health’s long-term borrowings rise?
Mohini Health’s long-term borrowings rose because its consolidated cash-flow statement reported Rs 112.48 crore of proceeds from long-term loans in the half year ended September 30, 2026. The closing balance reached Rs 115.12 crore, compared with Rs 2.64 crore at March 31, 2026 and Rs 3.98 crore at September 30, 2025.
The change in borrowings drove the increase in non-current liabilities, which rose to Rs 122.03 crore at September 30, 2026 from Rs 7.90 crore at the March 2026 year-end. Deferred tax liabilities were Rs 4.48 crore, compared with Rs 4.46 crore at March 31, while long-term provisions increased to Rs 97.35 lakh from Rs 80.55 lakh.
The rise in long-term debt was accompanied by a Rs 5.20 crore increase in shareholders’ funds, to Rs 93.87 crore. Minority interest of Rs 1.46 crore was also reported at September 30, 2026, whereas the March 2026 consolidated balance sheet showed no minority interest.
Where did Mohini Health deploy the financing proceeds?
Mohini Health deployed Rs 98.48 crore into short-term loans and advances during the half year, according to its consolidated investing cash flow. The balance-sheet line for short-term loans and advances increased to Rs 99.05 crore at September 30, 2026 from Rs 56.81 lakh at March 31, 2026 and Rs 4.55 crore a year earlier.
The filing records the movement as a negative Rs 98.48 crore under “Repayment/(Proceeds) of short term loans & advances” in investing cash flow, denoting a cash outflow. The company’s notes state that other income includes interest at 15% on loans and advances given to Winsome Yarns Limited, but they do not specify the amount of the Rs 99.05 crore balance attributable to that company.
Other income rose to Rs 11.37 crore in the half year ended September 30, 2026 from Rs 2.57 crore in the comparable 2025 period. Interest received in the cash-flow statement was Rs 9.61 crore, versus Rs 11.53 lakh a year earlier, while the results also include a Rs 8.36 crore loss on open forward contracts in the cash-flow reconciliation.
The loans-and-advances outflow was larger than the group’s other reported investing uses. Purchases of fixed assets, including capital work-in-progress, were Rs 1.12 crore, compared with Rs 7.91 crore in the prior-year half year; investment in shares was Rs 66.02 lakh and advances for capital assets were Rs 1.26 crore. Net cash used in investing activities consequently reached Rs 90.78 crore, against Rs 8.72 crore a year earlier.
Got a follow-up? Ask IRIS
How did the borrowing affect Mohini Health’s cash flow?
Mohini Health generated Rs 112.22 crore of net cash from financing activities in the half year ended September 30, 2026, compared with Rs 75.20 lakh in the corresponding 2025 period. Alongside Rs 112.48 crore of long-term loan proceeds, the company reported Rs 5.11 crore from short-term loans and paid Rs 5.38 crore of interest.
Operating activities used Rs 17.19 crore of cash, compared with an outflow of Rs 4.92 crore in the prior-year period. Operating profit before working-capital changes was Rs 12.28 crore, but the cash flow included a Rs 14.83 crore decrease in short-term provisions, a Rs 9.50 crore increase in other current assets and a Rs 3.19 crore increase in inventories.
Cash and cash equivalents increased by Rs 4.25 crore during the half year to Rs 9.74 crore at September 30, 2026, from Rs 5.49 crore at March 31, 2026. Current assets rose to Rs 210.23 crore from Rs 91.77 crore, with short-term loans and advances accounting for most of that Rs 118.46 crore increase.
Current liabilities were Rs 57.71 crore at September 30, 2026, compared with Rs 57.08 crore at March 31, 2026. The September subtotal included short-term borrowings of Rs 37.24 crore, other trade payables of Rs 6.66 crore, other current liabilities of Rs 4.24 crore and short-term provisions of Rs 8.66 crore.
What changed in Mohini Health’s consolidated operating results?
Mohini Health reported consolidated profit of Rs 5.20 crore for the half year ended September 30, 2026, compared with a Rs 3.95 crore loss in the corresponding period of 2025. Revenue from operations increased to Rs 110.43 crore from Rs 73.54 crore, while total income rose to Rs 121.80 crore from Rs 76.11 crore.
Financial costs increased to Rs 5.38 crore from Rs 1.82 crore year on year, consistent with the larger financing cash flows reported during the period. Cost of materials consumed rose to Rs 87.76 crore from Rs 54.66 crore, and export selling expenses increased to Rs 10.65 crore from Rs 4.86 crore.
Other expenses declined to Rs 3.66 crore from Rs 14.66 crore in the comparable half year. The company stated that 100% of its revenue comes from a single manufacturing segment, so the filing does not provide revenue, profit or asset figures by separate operating segment.
Property, plant and equipment stood at Rs 37.67 crore at September 30, 2026, down from Rs 39.90 crore at March 31, 2026. Capital work-in-progress increased to Rs 18.78 crore from Rs 17.72 crore, while inventories rose to Rs 39.59 crore from Rs 36.40 crore.
Conclusion
Mohini Health’s September 2026 consolidated statements show that a substantial expansion in long-term borrowing coincided with a much larger short-term loans-and-advances balance. The group recorded Rs 112.48 crore in long-term loan proceeds, Rs 98.48 crore of cash deployed into short-term loans and advances, and a closing long-term borrowing balance of Rs 115.12 crore, while returning to a Rs 5.20 crore half-year profit.
The key unresolved item is the composition and collection profile of the Rs 99.05 crore short-term loans-and-advances balance, as the filing identifies Winsome Yarns Limited as a recipient of advances carrying 15% interest but does not disclose its individual exposure. Future results will also show whether interest income, which was Rs 11.37 crore in the September 2026 half year, and finance costs of Rs 5.38 crore continue at similar levels.


